Life Science Technical Accounting Update Seminar 2022: You'll Hear from Experts at Deloitte, Ernst & Young, CFGI, Life Science Analysts, and Industry Counterparts (September 14-15, 2022) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Life Science Technical Accounting Update 2022" conference has been added to ResearchAndMarkets.com's offering.

From Gross to Net Estimates and Accruals to Preparing for an IPO to Government Pricing for Biotechs to Revenue Recognition examples and latest updates, this conference will address the latest developments in key areas. You'll hear from experts at Deloitte, Ernst & Young, CFGI, life science analysts, and your industry counterparts.

Learning Objectives:

• Understand the latest accounting changes in key areas
• Recognize the timelines and key factors affecting the life science industry
• Begin to assess the effects of these standards on your company or clients

This event will run from 8:45-4:40p (Pacific Time) each day.

Agenda:

Agenda: DAY 1

8:45 - 10:00

• Inventory Accounting Update
• Operating the commercial inventory accounting and reporting program
• Readiness: roadmap, policies and procedures, internal controls, roles and responsibilities, product costing methodology, R&D and invenotriable expenses, tools and technology
• Day 1: closing the books, journal entries, account reconciliations, executing controls, third party data, auditor considerations
• Run State: closing the books, journal entries, inventory tracking, management reporting, forecasting, inventory counts, valuation and standard costing, new products, and growth

10:00 - 10:10 - Break

10:10 - 11:30

• Revenue Recognition Update
• Cases and examples
• Interaction of 808 and 606
• Evaluating "active participation"
• Measure of progress
• SEC comment letter themes
• ASC 606 Implementation issues and lessons learned in the life science industry

11:30 - 11:40 - Break

11:40 - 1:05

• Technology Trends in Life Sciences
• Core Modernization
• Trust
• Business of Technology
• Data and Analytics and Artificial Intelligence
• Digital Experience and Digital Reality

1:05 - 2:05 - Lunch

2:05 - 3:05

• Accounting for R&D and New Product Launches
• R&D Funding Arrangements
• R&D Cost Classifications
• SEC Comment Letter Trends

3:05 - 3:10 - Break

3:10 - 4:40

• Tax Update
• Tax Policy Update
• Auditing Income Taxes
• COVID Impact - Remote Employees
• State Updates
• COVID Relief
• Section 382

Agenda: DAY 2

8:50 - 10:05

• Lease Modifications under ASC 842
• Discussion on future workplace & hybrid model of work
• Determining key assumptions in measuring the lease in this environment (e.g. discount rate)
• Evaluating certain transactions that may result from business interruption

10:05 - 10:20 - Break

10:20 - 11:40

• Fraud and Cybersecurity in Life Sciences
• Recent Trends
• Cases and Examples
• New threats from COVID
• Ransomware

11:40 - 11:45 - Break

11:45 - 1:00

• Accounting & Reporting Update:
• SEC Comment Letter themes
• MD&A Update
• Changing regulatory environment
• Non-GAAP measures
• ICFR material weaknesses
• Cybersecurity disclosures

1:00 - 1:30 - Lunch

1:30 - 2:55

• Valuation Update
• Fair value accounting
• Industry standards for valuation models
• Valuing IPR&D projects
• Valuation and impairment of intangible assets

2:55 - 3:10 - Break

3:10 - 4:40

• Trends in IPOs and SPAC Transactions
• Accounting considerations
• Typical steps
• IPO Trends
• Unicorns and timing give IPOs a lift
• Geopolitical and trade issues
• Outlook

For more information about this conference visit https://www.researchandmarkets.com/r/ypinvh